Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
147 hedge funds and large institutions have $677M invested in Surmodics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 53 reducing their positions, and 7 closing their positions.
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
7% more funds holding
Funds holding: 138 → 147 (+9)
0.46% more ownership
Funds ownership: 89.55% → 90.01% (+0.46%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $691M → $677M (-$13.6M)
8% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 53
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.81M |
| 2 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$4.43M |
| 3 |
Millennium Management
New York
|
+$3.13M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.02M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.57M |
| 2 |
EP
Eversept Partners
New York
|
-$2.69M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.31M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.13M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$1.74M |
SRDX Hedge Fund Activity: Q2 2021 in Review
147 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2021, worth a combined $677M — down 2% from $691M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SRDX positions and 7 closed out — a net gain of 9 holders — while 49 added to existing stakes and 53 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $6.81M. The largest seller was BlackRock, cutting an estimated $4.57M.
- 147 institutional investors held Surmodics (SRDX) as of Q2 2021, up from 138 in Q1 2021.
- Funds reported $677M of Surmodics stock for Q2 2021, down 2% quarter-over-quarter.
- 16 funds opened new Surmodics positions in Q2 2021 and 7 closed out, a net change of +9 holders.
- The largest Surmodics buyer in Q2 2021 was Soleus Capital Management, an estimated $6.81M added.
- The largest Surmodics seller in Q2 2021 was BlackRock, an estimated $4.57M sold.
Based on aggregated 13F filings for Q2 2021.